The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The Global Breast Cancer Burden
Abstract
Breast cancer now represents the most common female malignancy in both the developing and developed world, and is the primary cause of death among women globally. Despite well-documented reductions in mortality from breast cancer during the past two decades, incidence rates continue to increase and do so more rapidly in countries that historically had low rates. This has emphasized the importance of survivorship issues and optimal management of disease chronicity. This article reviews current trends of incidence and mortality in both a western and global context, and considers pertinent changes in underlying etiological risk factors. The latter not only offer clues regarding changes in incidence patterns, but also provides rationale and guidance for strategies that could potentially reduce the burden of this disease. The relevance of lifestyle adjustments and screening interventions for primary and secondary prevention, respectively, are discussed with reference to different healthcare resource settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J., & Ezzati, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67725-2 · Cited by 1,367
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725
Moderate Alcohol Intake and Cancer Incidence in Women
Allen, N. E., Beral, V., Casabonne, D., Kan, S. W., Reeves, G. K., Brown, A., Green, J., & Collaborators, O. B. O. T. M. W. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn514 · Cited by 600
The Effect of China's One-Child Family Policy after 25 Years
Hesketh, T., Lu, L., & Xing, Z. W. (2005) · New England Journal of Medicine · doi:10.1056/nejmhpr051833 · Cited by 596
“Westernizing” Women's Risks? Breast Cancer in Lower-Income Countries
Porter, P. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708307 · Cited by 558
Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M. (2010) · BMJ · doi:10.1136/bmj.c3620 · Cited by 412
Anderson, B. O., Shyyan, R., Eniu, A., Smith, R. A., Yip, C.-H., Bese, N. S., Chow, L. W. C., Masood, S., Ramsey, S. D., & Carlson, R. W. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00199.x · Cited by 359
Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
Holmberg, L., Iversen, O.-E., Rudenstam, C. M., Hammar, M., Kumpulainen, E., Jaskiewicz, J., Jassem, J., Dobaczewska, D., Fjosne, H. E., Peralta, O., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn058 · Cited by 344
Berclaz, G., Li, S., Price, K. N., Coates, A. S., Castiglione-Gertsch, M., Rudenstam, C.-M., Holmberg, S. B., Lindtner, J., Erien, D., Collins, J., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh222 · Cited by 257
Clinical Breast Examination: Preliminary Results from a Cluster Randomized Controlled Trial in India
Sankaranarayanan, R., Ramadas, K., Thara, S., Muwonge, R., Prabhakar, J., Augustine, P., Venugopal, M., Anju, G., & Mathew, B. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr304 · Cited by 243
Kwan, M. L., Kushi, L. H., Weltzien, E., Tam, E. K., Castillo, A., Sweeney, C., & Caan, B. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2730 · Cited by 231
Risk Factors for the Incidence of Breast Cancer: Do They Affect Survival From the Disease?
Barnett, G. C., Shah, M., Redman, K., Easton, D. F., Ponder, B. A. J., & Pharoah, P. D. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3168 · Cited by 207
Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
Jatoi, I., Anderson, W. F., Jeong, J.-H., & Redmond, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3550 · Cited by 172
Self-citationCleary, M. P., & Maihle, N. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44153b · Cited by 167
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
DeSantis, C., Howlader, N., Cronin, K. A., & Jemal, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0061 · Cited by 159
Linos, E., Spanos, D., ROSNER, B. A., Linos, K., Hesketh, T. M., Qu, J. D., Gao, Y., Zheng, W., & Colditz, G. A. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn305 · Cited by 148
Héry, C., Ferlay, J., Boniol, M., & Autier, P. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm593 · Cited by 98
Sprague, B. L., Trentham‐Dietz, A., Newcomb, P. A., Titus-Ernstoff, L. T., Hampton, J. M., & Egan, K. M. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0713 · Cited by 90
Age at first birth, parity and risk of breast cancer in a Swedish population
Adami, H., Hansen, J., Jung, B., & Rimsten, Å. (1980) · British Journal of Cancer · doi:10.1038/bjc.1980.298 · Cited by 67
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions
Anderson, W. F., Matsuno, R. K., Sherman, M. E., Lissowska, J., Gail, M. H., Brinton, L. A., Yang, X. R., Pepłońska, B., Chen, B. E., Rosenberg, P. S., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-006-0092-9 · Cited by 58
Cited by
Epidemiological characteristics of and risk factors for breast cancer in the world
Momenimovahed, Z., & Salehiniya, H. (2019) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s176070 · Cited by 1,050
Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study
Dianatinasab, M., Fararouei, M., Mohammadianpanah, M., & Zare-Bandamiri, M. (2016) · Medicine · doi:10.1097/md.0000000000004704 · Cited by 47
Metadata
- Authors
- Benson, J. R., & Jatoi, I.
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2012-06-30
- Volume
- 8
- Issue
- 6
- Pages
- 697-702
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- OpenAlex
- W2142628191
- Cited by
- 274
- References
- 29
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.